Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 11, 2024…
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…
Funded by a nearly £1.2M (~$1.5M USD) award, this research will enable ongoing validation of AccelADx™, a breakthrough screening test for…
TORONTO, July 11, 2024 /PRNewswire/ -- In a world where humans and high-volume digital connections are increasingly intertwined, consumers are…
Highlights Quentin Koffey’s Actions That Have Flown in the Face of Good GovernanceIRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”)…
Highlights Quentin Koffey’s Actions That Have Flown in the Face of Good GovernanceIRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”)…
Phase 2b RewinD-LB trial of neflamapimod for the treatment of dementia with Lewy bodies is fully enrolled with topline data…